IL2 and Opportunistic infection: We had previously observed improved CD4+ T-cell numbers and resolution of opportunistic infections in a patient with idiopathic CD4 lymphopenia treated with IL-2,34 and we reasoned that our patient who was immunocompromised from chemotherapy and immunotherapy might benefit from recombinant IL-2 treatment.